Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Cancer Association
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614217/ |